PROCEPT BioRobotics (PRCT) EBITDA Margin Growth (1y) (2021 - 2026)
PROCEPT BioRobotics (PRCT) EBITDA Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 102.00 |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn | 851.00 |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn | -313.00 |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | 241.00 |
| 10 | PROCEPT BioRobotics | 992.33 Mn | 746.69 Mn | 53.95 Mn | 45.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.00 |
| Dec 31, 2025 | -1,175.00 |
| Sep 30, 2025 | 1,059.00 |
| Jun 30, 2025 | 2,226.00 |
| Mar 31, 2025 | 2,241.00 |
| Dec 31, 2024 | 3,894.00 |
| Sep 30, 2024 | 3,453.00 |
| Jun 30, 2024 | 2,712.00 |
| Mar 31, 2024 | 5,420.00 |
| Dec 31, 2023 | 3,749.00 |
| Sep 30, 2023 | 3,567.00 |
| Jun 30, 2023 | 2,969.00 |
| Mar 31, 2023 | -567.00 |
| Dec 31, 2022 | 6,071.00 |
| Sep 30, 2022 | 3,901.00 |
| Jun 30, 2022 | 4,855.00 |
| Mar 31, 2022 | 4,712.00 |
| Dec 31, 2021 | 24,401.00 |
| Sep 30, 2021 | 37,339.00 |